Decellularization of donor pancreatic fragment to obtain a tissue-specific matrix scaffold

One of the pressing issues in tissue engineering is on how to obtain an artificial matrix that can simulate a biological microenvironment for cells. When creating a bioengineered pancreatic construct, a tissue-specific scaffold obtained from decellularized pancreatic tissue can serve as such matrix. Objective: to obtain and study the characteristic properties of a tissue-specific pancreas scaffold from decellularized human pancreatic fragments. Materials and methods. The decellularization protocol included 3 freeze/thaw cycles, followed by treatment with surfactants (sodium dodecyl sulfate and Triton X100). At each decellularization stage, samples were routinely stained with hematoxylin and eosin and for total collagen. In addition, immunohistochemical staining of decellularized human pancreas (DHP) for type I collagen and elastic fibers was performed. Cell nuclei in the original samples and the resulting matrix were visualized using DAPI fluorescent staining. DNA quantity in the native and decellularized pancreatic tissue was determined. The cytotoxicity of the tissue-specific matrix was evaluated in vitro by direct contact. The matrix properties of DHP samples were determined using mesenchymal stem cells (MSCs) of human adipose tissue. Results. A pancreatic decellularization method is proposed. This method allows to obtain a tissue-specific matrix in the form of a connective tissue scaffold completely free of detritus with preserved thin-fiber mesh-like structure, in which elastic and collagen fibers, including type I collagen, are identified. DAPI staining confirmed the absence of nuclear material in the decellularized matrix, while residual amount of DNA did not exceed 0.1%. Absence of matrix cytotoxicity and its ability to maintain adhesion and proliferation of human adipose tissue-derived MSCs was proved. Conclusion. As one of the stages in creating a bioengineered pancreatic construct, a method has been developed for producing a biocompatible (lack of cytotoxicity and immunogenicity) tissue-specific scaffold from decellularized human pancreatic tissue. In the scaffold, the morphofunctional properties of the native extracellular matrix-based scaffolds of the pancreas are preserved. Adhesion and proliferation of cell cultures are ensured.

pancreas, decellularization, tissue-specific scaffold, tissue engineering

1. Surguchenko VA. Matriksy dlya tkanevoj inzhenerii i gibridnyh organov. Biosovmestimye materialy (uchebnoe posobie). Pod red. V.I. Sevast’yanova i M.P. Kirpichnikova. M.: MIA, 2011. Chast’ II, glava 1: 199–226.

2. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011 April; 32 (12): 3233–3243. doi: 10.1016/j.biomaterials.2011.01.057.

3. Sackett SD, Tremmel DM, Ma F, Feeney AK, Maguire RM, Brown ME et al. Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Scientific Reports. 2018; 8: 10452. doi: 10.1038/s41598-018-28857-1.

4. Stendahl JC, Kaufman DB, Stupp SI. Extracellular Matrix in Pancreatic Islets: Relevance to Scaffold Design and Transplantation. Cell Transplant. 2009; 18 (1): 1–12. doi: 10.3727/096368909788237195.

5. Riopel M, Wang К. Collagen matrix support of pancreatic islet survival and function. Frontiers in Bioscience. 2014 Jan; 19: 77–90. doi: 10.2741/4196.

6. Salvatori M, Katari R, Patel T, Peloso A, Mugweru J, Owusu K, Orlando G. Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges. Journal of Diabetes Science and Technology. 2014; 8 (1): 159–169. doi: 10.1177/1932296813519558.

7. Wu D, Wan J, Huang Y, Guo Y, Xu T, Zhu M et al. 3D Culture of MIN-6 Cells on Decellularized Pancreatic Scaffold: in vitro and in vivo Study. BioMed Research International. 2015 Nov: 1–8. http://dx.doi.org/10.1155/2015/432645.

8. Goh SK, Bertera S, Olsen P, Candiello J, Halfter W, Uechi G et al. Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering. Biomaterials. 2013; 34 (28): 6760–6772. doi: 10.1016/j.biomaterials.2013.05.066.

9. Napierala H, Hillebrandt K-H, Haep N, Tang P, Tintemann M, Gassner J et al. Engineering an endocrine Neo-Pancreas by repopulation of a decellularized rat pancreas with islets of Langerhans. Scientific Reports. 2017; 7: 41777. doi: 10.1038/srep41777.

10. Mirmalek-Sani S-H, Orlando G, McQuilling J, Pareta R, Mack D, Salvatori M et al. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials. 2013; 34 (22): 5488–5495. doi: 10.1016/j.biomaterials.2013.03.054.

11. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas MEA et al. The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas. Ann Surg. 2016; 264 (1): 169–179. doi: 10.1097/SLA.0000000000001364.

12. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011. 32 (12): 3233–3243. doi: 10.1016/j.biomaterials.2011.01.057.

13. Mezhgosudarstvennyj standart GOST ISO 10993-5-2011 «Izdeliya medicinskie. Ocenka biologicheskogo dejstviya medicinskih izdelij. Chast’ 5. Issledovanie na citotoksichnost’: metody in vitro».